electroCore Inc.

6.02
0.04 (0.67%)
At close: Apr 17, 2025, 3:59 PM
6.79
12.79%
Pre-market: Apr 21, 2025, 08:36 AM EDT
0.67%
Bid 6
Market Cap 43.3M
Revenue (ttm) 25.18M
Net Income (ttm) -11.89M
EPS (ttm) -1.59
PE Ratio (ttm) -3.79
Forward PE 66.89
Analyst Buy
Ask 7
Volume 55,089
Avg. Volume (20D) 150,493
Open 5.93
Previous Close 5.98
Day's Range 5.78 - 6.12
52-Week Range 5.02 - 19.49
Beta 0.84

About ECOR

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or i...

Sector Healthcare
IPO Date Jun 22, 2018
Employees 73
Stock Exchange NASDAQ
Ticker Symbol ECOR
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for ECOR stock is "Buy." The 12-month stock price forecast is $25.5, which is an increase of 323.59% from the latest price.

Stock Forecasts
1 month ago
-26.54%
ElectroCore shares are trading lower after the com... Unlock content with Pro Subscription
4 months ago
+11.06%
ElectroCore shares are trading higher after HC Wainwright & Co. raised its price target on the stock from $22 to $25.